数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Jody R. Davids Independent Director 67 27.22万美元 未持股 2023-10-18
Marvin R. O'Quinn Independent Director 71 26.22万美元 未持股 2023-10-18
Helen M. Boudreau Independent Director 57 27.84万美元 未持股 2023-10-18
John T. Bigalke Independent Director 69 26.22万美元 未持股 2023-10-18
Peter S. Fine Independent Director 71 26.97万美元 未持股 2023-10-18
Ellen C. Wolf Independent Director 69 28.22万美元 未持股 2023-10-18
Marc D. Miller Independent Director 52 27.72万美元 未持股 2023-10-18
Michael J. Alkire President and Chief Executive Officer and Director 60 779.98万美元 未持股 2023-10-18
Richard J. Statuto Independent Director and Chair 66 26.97万美元 未持股 2023-10-18

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Leigh Anderson Chief Operating Officer 56 237.56万美元 未持股 2023-10-18
David L. Klatsky General Counsel 61 199.03万美元 未持股 2023-10-18
David A. Hargraves Senior Vice President of Supply Chain 54 144.44万美元 未持股 2023-10-18
Andrew F. Brailo -- Chief Customer Officer 52 未披露 未持股 2023-10-18
Crystal B. Climer -- Chief Accounting Officer 45 未披露 未持股 2023-10-18
Craig S. McKasson Chief Administrative and Financial Officer 56 347.09万美元 未持股 2023-10-18
Michael J. Alkire President and Chief Executive Officer and Director 60 779.98万美元 未持股 2023-10-18

董事简历

中英对照 |  中文 |  英文
Jody R. Davids

Jody R. Davids,自2015年1月起担任Premier的董事;自2014年4月起担任Agrium, Inc.(纽约证券交易所和多伦多证券交易所上市公司,农用和工业用肥料全球生产商与销售商)的首席信息官;2013年12月至2014年4月间担任Agrium的管理顾问,提供信息技术咨询服务,主要是技术和组织战略;2010年至2013年间担任Best Buy, Inc.(纽交所上市公司)的全球业务服务高级副总裁兼首席信息官;2000年至2009年间担任Cardinal Health, Inc.(纽交所上市公司)的多个职位,包括全球共享服务执行副总裁兼首席信息官(2007-2009)、执行副总裁兼首席信息官(2003-2007)。她获得了San Jose State University的学士学位和工商管理硕士学位。


Jody R. Davids,Senior Vice President and Global Chief Information Officer of PepsiCo, Inc., a NYSE-listed company that has a global portfolio of food and beverage brands, from April 2016 to October 2019;Chief Information Officer of Agrium, Inc., a NYSE-listed company and Toronto Stock Exchange-listed company that is a global producer and marketer of nutrients for agricultural and industrial markets, from April 2014 to April 2016;Various executive and consulting roles with Agrium, Best Buy, Inc., a NYSE-listed company, and Cardinal Health, Inc., a NYSE-listed company, during the period from 2000 to 2014;Obtained a bachelor's degree and a Master of Business Administration from San Jose State University;National Association of Corporate Directors "Board Leadership Fellow";CERT Certificate in Cybersecurity Oversight from the Carnegie Mellon University Software Engineering Institute.
Jody R. Davids,自2015年1月起担任Premier的董事;自2014年4月起担任Agrium, Inc.(纽约证券交易所和多伦多证券交易所上市公司,农用和工业用肥料全球生产商与销售商)的首席信息官;2013年12月至2014年4月间担任Agrium的管理顾问,提供信息技术咨询服务,主要是技术和组织战略;2010年至2013年间担任Best Buy, Inc.(纽交所上市公司)的全球业务服务高级副总裁兼首席信息官;2000年至2009年间担任Cardinal Health, Inc.(纽交所上市公司)的多个职位,包括全球共享服务执行副总裁兼首席信息官(2007-2009)、执行副总裁兼首席信息官(2003-2007)。她获得了San Jose State University的学士学位和工商管理硕士学位。
Jody R. Davids,Senior Vice President and Global Chief Information Officer of PepsiCo, Inc., a NYSE-listed company that has a global portfolio of food and beverage brands, from April 2016 to October 2019;Chief Information Officer of Agrium, Inc., a NYSE-listed company and Toronto Stock Exchange-listed company that is a global producer and marketer of nutrients for agricultural and industrial markets, from April 2014 to April 2016;Various executive and consulting roles with Agrium, Best Buy, Inc., a NYSE-listed company, and Cardinal Health, Inc., a NYSE-listed company, during the period from 2000 to 2014;Obtained a bachelor's degree and a Master of Business Administration from San Jose State University;National Association of Corporate Directors "Board Leadership Fellow";CERT Certificate in Cybersecurity Oversight from the Carnegie Mellon University Software Engineering Institute.
Marvin R. O'Quinn

Marvin R. O'Quinn,自2013年1月起担任American Healthcare Reit, Inc.的独立董事和薪酬委员会成员。自2019年2月以来,O'Quinn先生还担任位于伊利诺伊州芝加哥的CommonSpirit Health的总裁兼首席运营官,在那里他领导了尊严健康和天主教健康倡议合并后的卫生系统的增长和政策制定,该系统包括140家医院,约15万名员工和300亿美元的年收入。从2009年1月到2019年2月,他担任Dignity Health的高级执行副总裁兼首席运营官,这是一家位于加利福尼亚州旧金山的非营利公司,在加利福尼亚州,亚利桑那州和内华达州经营医院和辅助护理中心。2003年至2009年,他还担任位于佛罗里达州迈阿密的Jackson Health System的总裁兼首席执行官。在此之前,他从2000年到2003年担任新泽西州Florham Park的Atlantic Health System的执行副总裁兼首席运营官。他还曾担任纽约长老会健康系统(位于纽约,纽约州)以及普罗维登斯医疗中心和普罗维登斯密尔沃基医院(位于俄勒冈州波特兰市)的行政职务。此外,在整个职业生涯中,他曾在西北地区的其他医院和医疗中心担任重要职务,包括Legacy Emanuel医院和健康中心、Willamette Falls医院、Valley Children's Hospital和Harborview medical Center。他目前还担任Dignity Health Global Education(总部位于亚利桑那州凤凰城)的董事会主席,并担任First Initiatives Insurance, Ltd.(一家专属保险公司)的任命,以及First Initiatives Insurance, Ltd.(一家专属保险公司,总部位于科罗拉多州Englewood,服务于CommonSpirit Health)和Premier, Inc. (NASDAQ:该公司位于北卡罗来纳州夏洛特市,是一家在纳斯达克上市的医疗保健改善公司,于2013年10月完成了首次公开募股。他持有the University of Washington的卫生管理硕士学位和科学与生物学学士学位。


Marvin R. O'Quinn,has served as one of American Healthcare Reit, Inc. independent directors and a member of the Compensation Committee since January 2023. Mr. O'Quinn has also served as the President and Chief Operations Officer of CommonSpirit Health located in Chicago, Illinois, since February 2019, where he spearheaded the growth and policy development of a health system resulting from the merger of Dignity Health and Catholic Health Initiatives that included 140 hospitals, approximately 150,000 employees and $30 billion in annual revenue. From January 2009 until February 2019, Mr. O'Quinn served as the Senior Executive Vice President and Chief Operating Officer of Dignity Health, a not-for-profit corporation located in San Francisco, California, that operated hospitals and ancillary care centers located in California, Arizona and Nevada. He also served as President and Chief Executive Officer of Jackson Health System in Miami, Florida, from 2003 to 2009. Prior to that, Mr. O'Quinn served as Executive Vice President and Chief Operating Officer of Atlantic Health System in Florham Park, New Jersey, from 2000 until 2003. Mr. O'Quinn has also held executive positions with New York Presbyterian Health System, located in New York, New York, as well as Providence Medical Center and Providence Milwaukie Hospital, located in Portland, Oregon. Additionally, throughout his career, Mr. O'Quinn has held key positions within other hospitals and medical centers throughout the Northwest, including Legacy Emanuel Hospital & Health Center, Willamette Falls Hospital, Valley Children's Hospital and Harborview Medical Center. Mr. O'Quinn also currently serves as chairman of the board of directors for Dignity Health Global Education, headquartered in Phoenix, Arizona, and holds appointments with First Initiatives Insurance, Ltd., a captive insurance company appointments with First Initiatives Insurance, Ltd., a captive insurance company headquartered in Englewood, Colorado, that serves CommonSpirit Health, and Premier, Inc., (NASDAQ: PINC), located in Charlotte, North Carolina, a Nasdaq-listed healthcare improvement company that completed its initial public offering in October 2013. Mr. O'Quinn holds a master's degree in Health Administration and a bachelor's degree in Science and Biology from the University of Washington.
Marvin R. O'Quinn,自2013年1月起担任American Healthcare Reit, Inc.的独立董事和薪酬委员会成员。自2019年2月以来,O'Quinn先生还担任位于伊利诺伊州芝加哥的CommonSpirit Health的总裁兼首席运营官,在那里他领导了尊严健康和天主教健康倡议合并后的卫生系统的增长和政策制定,该系统包括140家医院,约15万名员工和300亿美元的年收入。从2009年1月到2019年2月,他担任Dignity Health的高级执行副总裁兼首席运营官,这是一家位于加利福尼亚州旧金山的非营利公司,在加利福尼亚州,亚利桑那州和内华达州经营医院和辅助护理中心。2003年至2009年,他还担任位于佛罗里达州迈阿密的Jackson Health System的总裁兼首席执行官。在此之前,他从2000年到2003年担任新泽西州Florham Park的Atlantic Health System的执行副总裁兼首席运营官。他还曾担任纽约长老会健康系统(位于纽约,纽约州)以及普罗维登斯医疗中心和普罗维登斯密尔沃基医院(位于俄勒冈州波特兰市)的行政职务。此外,在整个职业生涯中,他曾在西北地区的其他医院和医疗中心担任重要职务,包括Legacy Emanuel医院和健康中心、Willamette Falls医院、Valley Children's Hospital和Harborview medical Center。他目前还担任Dignity Health Global Education(总部位于亚利桑那州凤凰城)的董事会主席,并担任First Initiatives Insurance, Ltd.(一家专属保险公司)的任命,以及First Initiatives Insurance, Ltd.(一家专属保险公司,总部位于科罗拉多州Englewood,服务于CommonSpirit Health)和Premier, Inc. (NASDAQ:该公司位于北卡罗来纳州夏洛特市,是一家在纳斯达克上市的医疗保健改善公司,于2013年10月完成了首次公开募股。他持有the University of Washington的卫生管理硕士学位和科学与生物学学士学位。
Marvin R. O'Quinn,has served as one of American Healthcare Reit, Inc. independent directors and a member of the Compensation Committee since January 2023. Mr. O'Quinn has also served as the President and Chief Operations Officer of CommonSpirit Health located in Chicago, Illinois, since February 2019, where he spearheaded the growth and policy development of a health system resulting from the merger of Dignity Health and Catholic Health Initiatives that included 140 hospitals, approximately 150,000 employees and $30 billion in annual revenue. From January 2009 until February 2019, Mr. O'Quinn served as the Senior Executive Vice President and Chief Operating Officer of Dignity Health, a not-for-profit corporation located in San Francisco, California, that operated hospitals and ancillary care centers located in California, Arizona and Nevada. He also served as President and Chief Executive Officer of Jackson Health System in Miami, Florida, from 2003 to 2009. Prior to that, Mr. O'Quinn served as Executive Vice President and Chief Operating Officer of Atlantic Health System in Florham Park, New Jersey, from 2000 until 2003. Mr. O'Quinn has also held executive positions with New York Presbyterian Health System, located in New York, New York, as well as Providence Medical Center and Providence Milwaukie Hospital, located in Portland, Oregon. Additionally, throughout his career, Mr. O'Quinn has held key positions within other hospitals and medical centers throughout the Northwest, including Legacy Emanuel Hospital & Health Center, Willamette Falls Hospital, Valley Children's Hospital and Harborview Medical Center. Mr. O'Quinn also currently serves as chairman of the board of directors for Dignity Health Global Education, headquartered in Phoenix, Arizona, and holds appointments with First Initiatives Insurance, Ltd., a captive insurance company appointments with First Initiatives Insurance, Ltd., a captive insurance company headquartered in Englewood, Colorado, that serves CommonSpirit Health, and Premier, Inc., (NASDAQ: PINC), located in Charlotte, North Carolina, a Nasdaq-listed healthcare improvement company that completed its initial public offering in October 2013. Mr. O'Quinn holds a master's degree in Health Administration and a bachelor's degree in Science and Biology from the University of Washington.
Helen M. Boudreau

Helen M.Boudreau于2020年6月加入我们。Boudreau女士在生物技术、制药、咨询和银行业拥有30年的经验。最近,从2018年6月至2019年6月,她担任非营利生物技术比尔及梅林达·盖茨医学研究所的首席运营官。此前,她曾于2017年7月至2018年6月担任首席财务官,并于2016年2月至2017年7月担任ProteostasisTherapeutics,Inc.董事兼审计委员会主席2014年10月至2017年6月,她担任Forma Therapeutics,Inc.的首席财务官。2008年9月至2014年9月,Boudreau女士在Novartis担任高级财务职位,包括首席财务官Novartis Corporation US和首席财务官Global Oncology。从1999年4月到2008年9月,Boudreau女士在辉瑞公司(Pfizer)担任越来越多的战略与财务方面的职务和责任,包括Vice President金融客户业务部和商业运营部以及辉瑞全球研究与开发Vice President金融公司。Boudreau女士在百事可乐/百胜餐饮集团(PepsiCo/Yum!Brands,麦肯锡公司和美国银行。自2020年6月以来,她一直担任梦百合改进公司Premier,Inc.的董事会成员。她也任职Shattuck Labs公司、Field Trip Health公司、Rallybio公司的董事会。Boudreau女士在马里兰大学(University of Maryland)以优异成绩毕业并获得经济学学士学位,在弗吉尼亚大学(University of Virginia)达顿商学院(Darden Graduate School of Business)获得工商管理硕士学位。


Helen M. Boudreau,Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute, a nonprofit medical research organization, from June 2018 to June 2019;Previously served as the Chief Financial Officer at each of Proteostasis Therapeutics, Inc., a NASDAQ-listed biopharmaceutical company, from July 2017 to June 2018, and FORMA Therapeutics, Inc., a privately held biotechnology company, from October 2014 to June 2017;Prior experience includes executive positions with Novartis Corporation and Pfizer, Inc. and leadership roles with Pepsico/Yum! Brands, Inc., McKinsey & Company, Inc. and Bank of America Corporation;Serves on the board of directors and as Chair of the Audit Committee and member of the Compensation Committee of Shattuck Labs, Inc., a NASDAQ-listed company;Serves on the board of directors and as Chair of the Audit Committee of Rallybio Corporation, a NASDAQ-listed biotech company;Serves on the board of directors and the Audit Committee of Cara Therapeutics, a NASDAQ-listed company;Served on the board of directors and as chair of the Audit Committee and member of the Compensation Committee of Reunion Neuroscience (formerly Field Trip Health Ltd), a company formerly listed on the Toronto Stock Exchange and NASDAQ from 2020 to 2023;Served on the board of directors and as chair of the Audit Committee of Evaxion Biotech, a NASDAQ-listed company, from 2020 to 2021 and on the board of directors and as Chair of the Audit Committee and member of the Compensation Committee for Proteostasis Therapeutics, Inc. from 2016 to 2017;NACD Directorship Certified by the National Association of Corporate Directors;Obtained a bachelor's degree from the University of Maryland and a Master of Business Administration from the University of Virginia Darden Graduate School of Business;CERT Certificate in Cyber-Risk Oversight from the Carnegie Mellon University Software Engineering Institute and NACD.
Helen M.Boudreau于2020年6月加入我们。Boudreau女士在生物技术、制药、咨询和银行业拥有30年的经验。最近,从2018年6月至2019年6月,她担任非营利生物技术比尔及梅林达·盖茨医学研究所的首席运营官。此前,她曾于2017年7月至2018年6月担任首席财务官,并于2016年2月至2017年7月担任ProteostasisTherapeutics,Inc.董事兼审计委员会主席2014年10月至2017年6月,她担任Forma Therapeutics,Inc.的首席财务官。2008年9月至2014年9月,Boudreau女士在Novartis担任高级财务职位,包括首席财务官Novartis Corporation US和首席财务官Global Oncology。从1999年4月到2008年9月,Boudreau女士在辉瑞公司(Pfizer)担任越来越多的战略与财务方面的职务和责任,包括Vice President金融客户业务部和商业运营部以及辉瑞全球研究与开发Vice President金融公司。Boudreau女士在百事可乐/百胜餐饮集团(PepsiCo/Yum!Brands,麦肯锡公司和美国银行。自2020年6月以来,她一直担任梦百合改进公司Premier,Inc.的董事会成员。她也任职Shattuck Labs公司、Field Trip Health公司、Rallybio公司的董事会。Boudreau女士在马里兰大学(University of Maryland)以优异成绩毕业并获得经济学学士学位,在弗吉尼亚大学(University of Virginia)达顿商学院(Darden Graduate School of Business)获得工商管理硕士学位。
Helen M. Boudreau,Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute, a nonprofit medical research organization, from June 2018 to June 2019;Previously served as the Chief Financial Officer at each of Proteostasis Therapeutics, Inc., a NASDAQ-listed biopharmaceutical company, from July 2017 to June 2018, and FORMA Therapeutics, Inc., a privately held biotechnology company, from October 2014 to June 2017;Prior experience includes executive positions with Novartis Corporation and Pfizer, Inc. and leadership roles with Pepsico/Yum! Brands, Inc., McKinsey & Company, Inc. and Bank of America Corporation;Serves on the board of directors and as Chair of the Audit Committee and member of the Compensation Committee of Shattuck Labs, Inc., a NASDAQ-listed company;Serves on the board of directors and as Chair of the Audit Committee of Rallybio Corporation, a NASDAQ-listed biotech company;Serves on the board of directors and the Audit Committee of Cara Therapeutics, a NASDAQ-listed company;Served on the board of directors and as chair of the Audit Committee and member of the Compensation Committee of Reunion Neuroscience (formerly Field Trip Health Ltd), a company formerly listed on the Toronto Stock Exchange and NASDAQ from 2020 to 2023;Served on the board of directors and as chair of the Audit Committee of Evaxion Biotech, a NASDAQ-listed company, from 2020 to 2021 and on the board of directors and as Chair of the Audit Committee and member of the Compensation Committee for Proteostasis Therapeutics, Inc. from 2016 to 2017;NACD Directorship Certified by the National Association of Corporate Directors;Obtained a bachelor's degree from the University of Maryland and a Master of Business Administration from the University of Virginia Darden Graduate School of Business;CERT Certificate in Cyber-Risk Oversight from the Carnegie Mellon University Software Engineering Institute and NACD.
John T. Bigalke

JohnT.Bigalke,自2016年起担任梦百合战略公司Second Half Health Advisors的首席执行官。此前,1998年至2016年在德勤美国律师事务所(Deloitte USA LLP)任职,包括2002年至2012年担任医疗保健和生命科学实践的副主席兼国家行业领导者,2012年至2016年担任全球医疗保健实践的副主席兼高级合伙人。AdventHealth公司的董事、审计委员会主席、提名/公司和治理委员会成员、纳斯达克上市生物技术公司Progenity,Inc.特别委员会主席、审计委员会、财务和战略委员会以及风险和公司责任委员会的董事和无表决权成员。担任Concord梦百合Management Services,LLC和VaxCare,Inc.的顾问委员会成员。椅子。在Clemson University获得学士学位,在Columbia University Graduate School of Business完成领导力发展课程,在University of Pennsylvania沃顿商学院完成执行领导力课程。获得注册会计师执照。


John T. Bigalke,Chief Executive Officer of Second Half Health Advisors, a healthcare strategy firm, since 2016;Previously with Deloitte USA LLP from 1998 to 2016, including serving as Vice Chairman and National Industry Leader for the Health Care and Life Science Practice from 2002 until 2012 and Vice Chairman and Senior Partner, Global Health Care Practice from 2012 to 2016;Director, Chairman of the Audit and Corporate Responsibility Committee and member of the Finance Committee and Strategy Committee of AdventHealth;Former director, Audit Committee Chair and member of the Nominating and Governance Committee and Chair of the Special Committee of Biora Therapeutics, Inc. (formerly Progenity, Inc.), a NASDAQ-listed company;Obtained a bachelor's degree from Clemson University and completed the Leadership Development Program at Columbia University Graduate School of Business and the Executive Leadership Program at the Wharton School of the University of Pennsylvania;National Association of Corporate Directors "Board Leadership Fellow";CERT Certificate in Cybersecurity Oversight from the Carnegie Mellon University Software Engineering Institute;Lifetime member of the Florida Institute of Certified Public Accountants.
JohnT.Bigalke,自2016年起担任梦百合战略公司Second Half Health Advisors的首席执行官。此前,1998年至2016年在德勤美国律师事务所(Deloitte USA LLP)任职,包括2002年至2012年担任医疗保健和生命科学实践的副主席兼国家行业领导者,2012年至2016年担任全球医疗保健实践的副主席兼高级合伙人。AdventHealth公司的董事、审计委员会主席、提名/公司和治理委员会成员、纳斯达克上市生物技术公司Progenity,Inc.特别委员会主席、审计委员会、财务和战略委员会以及风险和公司责任委员会的董事和无表决权成员。担任Concord梦百合Management Services,LLC和VaxCare,Inc.的顾问委员会成员。椅子。在Clemson University获得学士学位,在Columbia University Graduate School of Business完成领导力发展课程,在University of Pennsylvania沃顿商学院完成执行领导力课程。获得注册会计师执照。
John T. Bigalke,Chief Executive Officer of Second Half Health Advisors, a healthcare strategy firm, since 2016;Previously with Deloitte USA LLP from 1998 to 2016, including serving as Vice Chairman and National Industry Leader for the Health Care and Life Science Practice from 2002 until 2012 and Vice Chairman and Senior Partner, Global Health Care Practice from 2012 to 2016;Director, Chairman of the Audit and Corporate Responsibility Committee and member of the Finance Committee and Strategy Committee of AdventHealth;Former director, Audit Committee Chair and member of the Nominating and Governance Committee and Chair of the Special Committee of Biora Therapeutics, Inc. (formerly Progenity, Inc.), a NASDAQ-listed company;Obtained a bachelor's degree from Clemson University and completed the Leadership Development Program at Columbia University Graduate School of Business and the Executive Leadership Program at the Wharton School of the University of Pennsylvania;National Association of Corporate Directors "Board Leadership Fellow";CERT Certificate in Cybersecurity Oversight from the Carnegie Mellon University Software Engineering Institute;Lifetime member of the Florida Institute of Certified Public Accountants.
Peter S. Fine

Peter S. Fine自2013年10月以来担任Premier的董事。他之前从2003年到2009年在PHSI的董事会工作。自2000年以来他担任Banner Health(Premier的持有者成员之一)的总裁兼首席执行官。他目前担任Banner Health董事会成员。此外,他之前在Accuray Incorporated和the Translational Genomics Research Institute的董事会工作,是Heard Museum理事会成员。他持有俄亥俄大学(Ohio University)的学士学位和乔治华盛顿大学(George Washington University)医疗保健管理硕士学位。


Peter S. Fine,President and Chief Executive Officer of Banner Health since 2000;Member of the board of directors of Banner Health;Member of the board of directors of Premier's predecessors from 2003 through 2009;Previously served on the boards of directors of Accuray Incorporated and the Translational Genomics Research Institute and as member of the Heard Museum board of trustees;Obtained a bachelor's degree from Ohio University and Master of Arts in Healthcare Administration from George Washington University.
Peter S. Fine自2013年10月以来担任Premier的董事。他之前从2003年到2009年在PHSI的董事会工作。自2000年以来他担任Banner Health(Premier的持有者成员之一)的总裁兼首席执行官。他目前担任Banner Health董事会成员。此外,他之前在Accuray Incorporated和the Translational Genomics Research Institute的董事会工作,是Heard Museum理事会成员。他持有俄亥俄大学(Ohio University)的学士学位和乔治华盛顿大学(George Washington University)医疗保健管理硕士学位。
Peter S. Fine,President and Chief Executive Officer of Banner Health since 2000;Member of the board of directors of Banner Health;Member of the board of directors of Premier's predecessors from 2003 through 2009;Previously served on the boards of directors of Accuray Incorporated and the Translational Genomics Research Institute and as member of the Heard Museum board of trustees;Obtained a bachelor's degree from Ohio University and Master of Arts in Healthcare Administration from George Washington University.
Ellen C. Wolf

Ellen C. Wolf女士自2013年10月起任Premier公司董事。从2006年到2013年,Wolf女士任American Water Works Company, Inc.公司高级副总裁及首席财务官,该公司是美国最大的投资者所有水务和废水公司。此前,从2003年起,她曾任USEC, Inc.公司高级副总裁及首席财务官,从1999年到2003年,她曾任American Water Works公司副总裁及首席财务官。在那之前,自1979年职业生涯伊始,Wolf女士担任各种公司会计职务、财务职务及业务拓展职务,承担越来越重要的责任。自2008年起她任Airgas, Inc.公司董事,该公司在纽约证券交易所上市,她还任Philadelphia Zoo和两家私营公司董事会董事。Wolf女士拥有杜克大学学士学位及宾夕法尼亚大学工商管理硕士学位。


Ellen C. Wolf,Previously served as Chief Financial Officer of American Water Works Company, Inc., the largest investor- owned U.S. water and wastewater company, as Senior Vice President and Chief Financial Officer of USEC, Inc. and as Vice President and Chief Financial Officer of American Water Works;Former director of Connecticut Water, a NASDAQ-listed company, from 2015 until its sale in 2019, and former director and Chair of the audit committee of InfraREIT, L.L.C., a NYSE-listed company, from 2014 until its sale in 2019;Former director of Airgas, Inc., a NYSE-listed company, and the Philadelphia Zoo;Obtained a bachelor's degree from Duke University and a Master of Business Administration from the Wharton School of the University of Pennsylvania.
Ellen C. Wolf女士自2013年10月起任Premier公司董事。从2006年到2013年,Wolf女士任American Water Works Company, Inc.公司高级副总裁及首席财务官,该公司是美国最大的投资者所有水务和废水公司。此前,从2003年起,她曾任USEC, Inc.公司高级副总裁及首席财务官,从1999年到2003年,她曾任American Water Works公司副总裁及首席财务官。在那之前,自1979年职业生涯伊始,Wolf女士担任各种公司会计职务、财务职务及业务拓展职务,承担越来越重要的责任。自2008年起她任Airgas, Inc.公司董事,该公司在纽约证券交易所上市,她还任Philadelphia Zoo和两家私营公司董事会董事。Wolf女士拥有杜克大学学士学位及宾夕法尼亚大学工商管理硕士学位。
Ellen C. Wolf,Previously served as Chief Financial Officer of American Water Works Company, Inc., the largest investor- owned U.S. water and wastewater company, as Senior Vice President and Chief Financial Officer of USEC, Inc. and as Vice President and Chief Financial Officer of American Water Works;Former director of Connecticut Water, a NASDAQ-listed company, from 2015 until its sale in 2019, and former director and Chair of the audit committee of InfraREIT, L.L.C., a NYSE-listed company, from 2014 until its sale in 2019;Former director of Airgas, Inc., a NYSE-listed company, and the Philadelphia Zoo;Obtained a bachelor's degree from Duke University and a Master of Business Administration from the Wharton School of the University of Pennsylvania.
Marc D. Miller

Marc D. Miller,2009年5月,他被任命为Aeropostale公司总裁。在2007年,他担任紧急医护部高级副总裁和 联合负责人;2005年起,他担任副总裁;2004年8月起,他担任紧急医护部副总裁;2003年6月起,他在Universal Health Services担任副总裁助理职务和东部地区紧急医护部集团董事;2002年2月至2003年5月,他在Central Montgomery Medical Center担任首席执行官/常务董事;2000年10月至2002年2月,他在Wellington Regional Medical Center担任首席运营官;1999年8月至2000年10月,他在The George Washington University Hospital担任行政助理。他是Universal Health Realty Income Trust理事,也是Aeropostale公司首席行政官和董事会主席Alan B. Miller的儿子。


Marc D. Miller,was appointed Chief Executive Officer and President effective January 1, 2021. He has served as President since May, 2009 and prior thereto served as Senior Vice President and co-head of Universal Health Services, Inc. Acute Care Hospitals since 2007. He was elected a Director in May, 2006 and Vice President in 2005. He has served in various capacities related to Universal Health Services, Inc. acute care division since 2000. He was elected to the Board of Trustees of Universal Health Realty Income Trust in December, 2008. In August, 2015, he was appointed to the Board of Directors of Premier, Inc., a publicly traded healthcare performance improvement alliance.
Marc D. Miller,2009年5月,他被任命为Aeropostale公司总裁。在2007年,他担任紧急医护部高级副总裁和 联合负责人;2005年起,他担任副总裁;2004年8月起,他担任紧急医护部副总裁;2003年6月起,他在Universal Health Services担任副总裁助理职务和东部地区紧急医护部集团董事;2002年2月至2003年5月,他在Central Montgomery Medical Center担任首席执行官/常务董事;2000年10月至2002年2月,他在Wellington Regional Medical Center担任首席运营官;1999年8月至2000年10月,他在The George Washington University Hospital担任行政助理。他是Universal Health Realty Income Trust理事,也是Aeropostale公司首席行政官和董事会主席Alan B. Miller的儿子。
Marc D. Miller,was appointed Chief Executive Officer and President effective January 1, 2021. He has served as President since May, 2009 and prior thereto served as Senior Vice President and co-head of Universal Health Services, Inc. Acute Care Hospitals since 2007. He was elected a Director in May, 2006 and Vice President in 2005. He has served in various capacities related to Universal Health Services, Inc. acute care division since 2000. He was elected to the Board of Trustees of Universal Health Realty Income Trust in December, 2008. In August, 2015, he was appointed to the Board of Directors of Premier, Inc., a publicly traded healthcare performance improvement alliance.
Michael J. Alkire

Michael J. Alkire,2013年以来,他一直担任Premier公司的首席营运官。他曾一直担任PHSI公司和Premier公司的类似职务(2011年以来),也曾担任PHSI公司的董事会成员和Premier Plans公司的管理委员会成员(从2011年到2013年)。他于2004年加入Premier公司,担任高级副总裁,直到他被任命为Premier公司的总裁(从2006年到2011年)。他此前也曾担任德勤会计师事务所(Deloitte & Touche)和Cap Gemini Ernst & Young的执行职务。他是the East Coast Healthcare Executive Summit的成员,以及Global Healthcare Exchange公司、HSCA公司和the Dallas Mustangs(在德克萨斯州北部一个游泳项目)的董事会前任董事。他持有Indiana State University的学士学位,以及Indiana University的工商管理硕士学位。


Michael J. Alkire,Chief Executive Officer of Premier since May 2021 and President of Premier since April 2019;Chief Operating Officer of Premier (2013 to April 2019), and of PHSI and Premier LP since 2011;Senior Vice President of Premier from 2004 to 2006 and President of Premier LP from 2006 to 2011;Member of the board of directors of Premier's predecessors from 2011 to 2013;Prior executive experience includes positions at Deloitte & Touche LLP and Cap Gemini Ernst & Young;Past director on the boards of directors of FFF Enterprises, Inc., Global Healthcare Exchange, LLC and the Healthcare Supply Chain Association;Obtained a bachelor's degree from Indiana State University and a Master of Business Administration from Indiana University.
Michael J. Alkire,2013年以来,他一直担任Premier公司的首席营运官。他曾一直担任PHSI公司和Premier公司的类似职务(2011年以来),也曾担任PHSI公司的董事会成员和Premier Plans公司的管理委员会成员(从2011年到2013年)。他于2004年加入Premier公司,担任高级副总裁,直到他被任命为Premier公司的总裁(从2006年到2011年)。他此前也曾担任德勤会计师事务所(Deloitte & Touche)和Cap Gemini Ernst & Young的执行职务。他是the East Coast Healthcare Executive Summit的成员,以及Global Healthcare Exchange公司、HSCA公司和the Dallas Mustangs(在德克萨斯州北部一个游泳项目)的董事会前任董事。他持有Indiana State University的学士学位,以及Indiana University的工商管理硕士学位。
Michael J. Alkire,Chief Executive Officer of Premier since May 2021 and President of Premier since April 2019;Chief Operating Officer of Premier (2013 to April 2019), and of PHSI and Premier LP since 2011;Senior Vice President of Premier from 2004 to 2006 and President of Premier LP from 2006 to 2011;Member of the board of directors of Premier's predecessors from 2011 to 2013;Prior executive experience includes positions at Deloitte & Touche LLP and Cap Gemini Ernst & Young;Past director on the boards of directors of FFF Enterprises, Inc., Global Healthcare Exchange, LLC and the Healthcare Supply Chain Association;Obtained a bachelor's degree from Indiana State University and a Master of Business Administration from Indiana University.
Richard J. Statuto

Richard J. Statuto,Statuto先生从2013年5月开始担任Premier的董事兼董事会主席。从2011年到2013年,他担任PHSI的董事,并担任Premier Plans的管理委员会委员。Statuto先生从2005年开始担任Bon Secours Health System的总裁兼首席执行官,Bon Secours Health System在美国东部地区的7个州拥有超过30家工厂,并是Premier股东之一。在这之前,从1995年到2004年,他担任St. Joseph Health System的总裁兼首席执行官。Statuto先生目前担任Covenant Health Systems, Inc.、仁慈房屋公司(Mercy Housing, Inc.)与Catholic CEO Healthcare Connection。 的董事。在这之前,Statuto先生担任凯玛特公司(Kmart Corporation)的董事,担任天主教卫生协会(Catholic Health Association)的董事会主席,并担任Christus Health System的董事会副主席。Statuto先生在范德比大学(Vanderbilt University)获得化学工程学士学位,并在泽维尔大学(Xavier University)获得工商管理硕士学位。


Richard J. Statuto,Chair of the Board of Directors of Premier from 2013 to August 2019 and from October 2023 to the present, and member of the board of directors of Premier and its predecessors since 2011;Advisor to Bon Secours Mercy Health, primarily focused on strategic growth and innovation, from September 2018 through August 2019;President and Chief Executive Officer of Bon Secours Health System from 2005 to September 2018;Previously served as President and Chief Executive Officer of St. Joseph Health System;Served on the boards of directors of the Catholic Medical Mission Board and the Innovation Institute;Served as Chair of the board of directors of the Catholic Health Association and as Vice Chair of the board of directors of Christus Health System;Obtained a bachelor's degree in chemical engineering from Vanderbilt University and a Master of Business Administration from Xavier University.
Richard J. Statuto,Statuto先生从2013年5月开始担任Premier的董事兼董事会主席。从2011年到2013年,他担任PHSI的董事,并担任Premier Plans的管理委员会委员。Statuto先生从2005年开始担任Bon Secours Health System的总裁兼首席执行官,Bon Secours Health System在美国东部地区的7个州拥有超过30家工厂,并是Premier股东之一。在这之前,从1995年到2004年,他担任St. Joseph Health System的总裁兼首席执行官。Statuto先生目前担任Covenant Health Systems, Inc.、仁慈房屋公司(Mercy Housing, Inc.)与Catholic CEO Healthcare Connection。 的董事。在这之前,Statuto先生担任凯玛特公司(Kmart Corporation)的董事,担任天主教卫生协会(Catholic Health Association)的董事会主席,并担任Christus Health System的董事会副主席。Statuto先生在范德比大学(Vanderbilt University)获得化学工程学士学位,并在泽维尔大学(Xavier University)获得工商管理硕士学位。
Richard J. Statuto,Chair of the Board of Directors of Premier from 2013 to August 2019 and from October 2023 to the present, and member of the board of directors of Premier and its predecessors since 2011;Advisor to Bon Secours Mercy Health, primarily focused on strategic growth and innovation, from September 2018 through August 2019;President and Chief Executive Officer of Bon Secours Health System from 2005 to September 2018;Previously served as President and Chief Executive Officer of St. Joseph Health System;Served on the boards of directors of the Catholic Medical Mission Board and the Innovation Institute;Served as Chair of the board of directors of the Catholic Health Association and as Vice Chair of the board of directors of Christus Health System;Obtained a bachelor's degree in chemical engineering from Vanderbilt University and a Master of Business Administration from Xavier University.

高管简历

中英对照 |  中文 |  英文
Leigh Anderson

Leigh Anderson,2016年6月以来,他一直担任Premier公司的首席信息官。他于2013年加入Premier公司,担任首席运营官,负责信息和技术服务。加入Premier公司之前,他曾担任Hospital Corporation of America(医疗服务供应商,本土管理医院和外科中心)的首席信息官,负责健康信托和Parallon供应链(2011年至2013年)。他此前曾担任Global Healthcare Exchange GHX、Longmont United Hospital、Whittman-Hart、US West、AT&T的领先信息职务。他此前曾任职于GS1公司(一个国际供应链标准组织,拥有1000000以上的成员公司)的美国董事会,也任职于GHX公司的董事会。他持有Hofstra University的学士学位,以及Wake Forest University的工商管理硕士学位。


Leigh Anderson,Chief Operating Officer of Premier since September 2023;President of Performance Services from July 2018 to September 2023;Chief Information Officer of Premier from 2016 to 2018 and Chief Operating Officer for Information and Technology Services from 2013 to 2016;Previously CIO of HealthTrust and Parallon Supply Chain at Hospital Corporation of America, a healthcare service provider consisting of locally managed hospitals and surgical centers, from 2011 to 2013;Prior lead informatics roles with Global Healthcare Exchange, LLC, Longmont United Hospital, Whittman-Hart, US West and AT&T;Previously served on the U.S. governing board of GS1, an international supply chain standards body with over 1,000,000 member companies, and on the board of directors of GHX;Obtained a bachelor's degree from Hofstra University and a Master of Business Administration from Wake Forest University.
Leigh Anderson,2016年6月以来,他一直担任Premier公司的首席信息官。他于2013年加入Premier公司,担任首席运营官,负责信息和技术服务。加入Premier公司之前,他曾担任Hospital Corporation of America(医疗服务供应商,本土管理医院和外科中心)的首席信息官,负责健康信托和Parallon供应链(2011年至2013年)。他此前曾担任Global Healthcare Exchange GHX、Longmont United Hospital、Whittman-Hart、US West、AT&T的领先信息职务。他此前曾任职于GS1公司(一个国际供应链标准组织,拥有1000000以上的成员公司)的美国董事会,也任职于GHX公司的董事会。他持有Hofstra University的学士学位,以及Wake Forest University的工商管理硕士学位。
Leigh Anderson,Chief Operating Officer of Premier since September 2023;President of Performance Services from July 2018 to September 2023;Chief Information Officer of Premier from 2016 to 2018 and Chief Operating Officer for Information and Technology Services from 2013 to 2016;Previously CIO of HealthTrust and Parallon Supply Chain at Hospital Corporation of America, a healthcare service provider consisting of locally managed hospitals and surgical centers, from 2011 to 2013;Prior lead informatics roles with Global Healthcare Exchange, LLC, Longmont United Hospital, Whittman-Hart, US West and AT&T;Previously served on the U.S. governing board of GS1, an international supply chain standards body with over 1,000,000 member companies, and on the board of directors of GHX;Obtained a bachelor's degree from Hofstra University and a Master of Business Administration from Wake Forest University.
David L. Klatsky

David L. Klatsky,他曾一直担任Premier公司的法律总顾问(2016年7月以来)。加入Premier公司之前,他曾从事法律实践(1992年至2016年),任职于McDermott Will & Emery LLP MWE的全球律师事务所,在那里他曾担任MWE公司的健康事务合伙人。任职MWE期间,他曾任职Premier公司及其附属公司(1996年创立组织以来),包括担任首席外部顾问(2007年至2016年)。他是全国公认的医疗法律专家,帮助领导Premier公司通过其2013年首次公开发行和企业重组。他的职业生涯包括建议财富500强企业、私人股本公司、营利性和免税医疗服务客户,涉及医疗保健行业的合并、收购和合资企业的事务和监管方面。他曾从事企业和医疗法律实践25年以上,也曾担任多种健康产业交易的首席律师。他持有Brown University的学士学位,以及the University of California-Los Angeles School of Law的法学博士学位。


David L. Klatsky,General Counsel of Premier since July 2016;Partner in the health practice group of McDermott Will & Emery LLP from 1992 to 2016, where he worked extensively with Premier and its affiliated companies since the organization's founding in 1996 through its initial public offering and corporate restructure in 2013 and served as chief outside counsel from 2007 to 2016;Advised Fortune 500 companies, private equity firms and for-profit and tax-exempt healthcare services clients on the transactional and regulatory aspects of mergers, acquisitions and joint ventures in the healthcare sector and acted as the lead lawyer in a broad cross section of health industry transactions;Obtained a bachelor's degree from Brown University and a Juris Doctor degree from the University of California—Los Angeles School of Law.
David L. Klatsky,他曾一直担任Premier公司的法律总顾问(2016年7月以来)。加入Premier公司之前,他曾从事法律实践(1992年至2016年),任职于McDermott Will & Emery LLP MWE的全球律师事务所,在那里他曾担任MWE公司的健康事务合伙人。任职MWE期间,他曾任职Premier公司及其附属公司(1996年创立组织以来),包括担任首席外部顾问(2007年至2016年)。他是全国公认的医疗法律专家,帮助领导Premier公司通过其2013年首次公开发行和企业重组。他的职业生涯包括建议财富500强企业、私人股本公司、营利性和免税医疗服务客户,涉及医疗保健行业的合并、收购和合资企业的事务和监管方面。他曾从事企业和医疗法律实践25年以上,也曾担任多种健康产业交易的首席律师。他持有Brown University的学士学位,以及the University of California-Los Angeles School of Law的法学博士学位。
David L. Klatsky,General Counsel of Premier since July 2016;Partner in the health practice group of McDermott Will & Emery LLP from 1992 to 2016, where he worked extensively with Premier and its affiliated companies since the organization's founding in 1996 through its initial public offering and corporate restructure in 2013 and served as chief outside counsel from 2007 to 2016;Advised Fortune 500 companies, private equity firms and for-profit and tax-exempt healthcare services clients on the transactional and regulatory aspects of mergers, acquisitions and joint ventures in the healthcare sector and acted as the lead lawyer in a broad cross section of health industry transactions;Obtained a bachelor's degree from Brown University and a Juris Doctor degree from the University of California—Los Angeles School of Law.
David A. Hargraves

DavidA.Hargraves,自2017年7月起担任Premier供应链高级副总裁。Premier2015年至2017年战略采购Vice President。曾于2006年至2015年担任匹兹堡大学医学中心临床供应链Vice President。曾任职务包括查塔姆大学可持续供应链管理兼职教授、美国铝业公司和Ariba Inc.供应链领导职务以及美国海军医院医务人员和生物医学设备技术员。在Penn State University获得生物医学工程技术理学学士学位,在Duquesne University获得学士学位,在Waynesburg University获得工商管理硕士学位,专注于梦百合金融。


David A. Hargraves,Senior Vice President of Supply Chain of Premier since July 2017;Vice President of Strategic Sourcing of Premier from 2015 to 2017;Previously Vice President of Clinical Supply Chain at University of Pittsburgh Medical Center from 2006 to 2015;Prior roles include adjunct professor of sustainable supply chain management at Chatham University, supply chain leadership roles with Alcoa Corporation and Ariba Inc. and hospital corpsman and biomedical equipment technician for the U.S. Navy;Obtained a Master of Business Administration with a concentration in healthcare finance from Waynesburg University, a bachelor's degree from Duquesne University and an Associates of Science degree in biomedical engineering technology from Penn State University.
DavidA.Hargraves,自2017年7月起担任Premier供应链高级副总裁。Premier2015年至2017年战略采购Vice President。曾于2006年至2015年担任匹兹堡大学医学中心临床供应链Vice President。曾任职务包括查塔姆大学可持续供应链管理兼职教授、美国铝业公司和Ariba Inc.供应链领导职务以及美国海军医院医务人员和生物医学设备技术员。在Penn State University获得生物医学工程技术理学学士学位,在Duquesne University获得学士学位,在Waynesburg University获得工商管理硕士学位,专注于梦百合金融。
David A. Hargraves,Senior Vice President of Supply Chain of Premier since July 2017;Vice President of Strategic Sourcing of Premier from 2015 to 2017;Previously Vice President of Clinical Supply Chain at University of Pittsburgh Medical Center from 2006 to 2015;Prior roles include adjunct professor of sustainable supply chain management at Chatham University, supply chain leadership roles with Alcoa Corporation and Ariba Inc. and hospital corpsman and biomedical equipment technician for the U.S. Navy;Obtained a Master of Business Administration with a concentration in healthcare finance from Waynesburg University, a bachelor's degree from Duquesne University and an Associates of Science degree in biomedical engineering technology from Penn State University.
Andrew F. Brailo

Andrew F. Brailo,自2023年9月起担任Premier首席商务官;2015年7月至2023年9月担任首席客户官、会员外勤事务高级副总裁;自2001年加入Premier以来,在会员外勤事务中担任关键领导职务,包括外勤培训和发展、会员和外勤沟通以及关键和技术外勤专家的发展;获得库茨敦大学学士学位。


Andrew F. Brailo,Chief Commercial Officer of Premier since September 2023;Chief Customer Officer Senior Vice President of Member Field Services from July 2015 to September 2023;Served in key leadership roles in member field services for Premier since joining in 2001, including field training and development, member and field communications and development of critical and technical field specialists;Obtained a bachelor's degree from Kutztown University.
Andrew F. Brailo,自2023年9月起担任Premier首席商务官;2015年7月至2023年9月担任首席客户官、会员外勤事务高级副总裁;自2001年加入Premier以来,在会员外勤事务中担任关键领导职务,包括外勤培训和发展、会员和外勤沟通以及关键和技术外勤专家的发展;获得库茨敦大学学士学位。
Andrew F. Brailo,Chief Commercial Officer of Premier since September 2023;Chief Customer Officer Senior Vice President of Member Field Services from July 2015 to September 2023;Served in key leadership roles in member field services for Premier since joining in 2001, including field training and development, member and field communications and development of critical and technical field specialists;Obtained a bachelor's degree from Kutztown University.
Crystal B. Climer

Crystal B. Climer,自2022年9月起担任Premier的首席会计官;2019年11月至2022年9月担任Premier的财务总监;2018年7月至2019年11月担任高级会计总监;拥有20多年的会计和财务领导经验;曾在BSN Medical、Roush Yates Engines和Springs Creative Products Group担任会计和财务领导职务;曾在北卡罗来纳州担任注册会计师、注册管理会计师和注册欺诈审查员。


Crystal B. Climer,Chief Accounting Officer of Premier since September 2022;Controller of Premier from November 2019 to September 2022;Senior Director of Accounting July 2018 to November 2019;Over 20 years of accounting and finance leadership;Former accounting and finance leadership roles at BSN Medical, Roush Yates Engines and Springs Creative Products Group;Certified Public Accountant in North Carolina, Certified Management Accountant and Certified Fraud Examiner.
Crystal B. Climer,自2022年9月起担任Premier的首席会计官;2019年11月至2022年9月担任Premier的财务总监;2018年7月至2019年11月担任高级会计总监;拥有20多年的会计和财务领导经验;曾在BSN Medical、Roush Yates Engines和Springs Creative Products Group担任会计和财务领导职务;曾在北卡罗来纳州担任注册会计师、注册管理会计师和注册欺诈审查员。
Crystal B. Climer,Chief Accounting Officer of Premier since September 2022;Controller of Premier from November 2019 to September 2022;Senior Director of Accounting July 2018 to November 2019;Over 20 years of accounting and finance leadership;Former accounting and finance leadership roles at BSN Medical, Roush Yates Engines and Springs Creative Products Group;Certified Public Accountant in North Carolina, Certified Management Accountant and Certified Fraud Examiner.
Craig S. McKasson

Craig S. McKasson,2013年以来,他曾一直担任Premier公司的高级副总裁兼首席财务官(2013年以来)。他曾担任PHSI公司和Premier LP的相似职务(2010年以来)。此前,他曾担任上诉实体的副总裁兼公司总会计师(从1997年到2010年)。他目前担任Innovatix公司的管理委员会成员、Saint Vincent De Paul Village公司的执行委员会和董事会成员,以及Saint Vincent De Paul Village公司的财务主管兼审计委员会主席。从2010年到2014年,他曾担任Global Healthcare Exchange公司的董事会和审计委员会成员,以及薪酬委员会成员(从2013年到2014年)。他是美国注册会计师协会(the American Institute of Certified Public Accountants)和加州注册会计师协会(the California Society of Certified Public Accountants。)的成员。他持有San Diego State University的工商管理学士学位和会计硕士学位。


Craig S. McKasson,Chief Administrative Officer of Premier since April 2019, and Senior Vice President and Chief Financial Officer since 2013;Chief Financial Officer of PHSI and Premier LP since 2010 and Vice President and Corporate Controller of PHSI and Premier LP from 1997 to 2010;Member of the board of directors of the San Diego State University Fowler College of Business;Member of the board of managers of FFF Enterprises, Inc. and Nufactor, Inc. since January 2021;Former board member and current member of the finance committee of Saint Vincent De Paul Village Inc. (dba Father Joes Villages);Former member of the board of Global Healthcare Exchange, LLC and Innovatix, LLC;Member of the American Institute of Certified Public Accountants and the California Society of Certified Public Accountants;Obtained a bachelor's degree in business administration and a Master of Science in accountancy from San Diego State University.
Craig S. McKasson,2013年以来,他曾一直担任Premier公司的高级副总裁兼首席财务官(2013年以来)。他曾担任PHSI公司和Premier LP的相似职务(2010年以来)。此前,他曾担任上诉实体的副总裁兼公司总会计师(从1997年到2010年)。他目前担任Innovatix公司的管理委员会成员、Saint Vincent De Paul Village公司的执行委员会和董事会成员,以及Saint Vincent De Paul Village公司的财务主管兼审计委员会主席。从2010年到2014年,他曾担任Global Healthcare Exchange公司的董事会和审计委员会成员,以及薪酬委员会成员(从2013年到2014年)。他是美国注册会计师协会(the American Institute of Certified Public Accountants)和加州注册会计师协会(the California Society of Certified Public Accountants。)的成员。他持有San Diego State University的工商管理学士学位和会计硕士学位。
Craig S. McKasson,Chief Administrative Officer of Premier since April 2019, and Senior Vice President and Chief Financial Officer since 2013;Chief Financial Officer of PHSI and Premier LP since 2010 and Vice President and Corporate Controller of PHSI and Premier LP from 1997 to 2010;Member of the board of directors of the San Diego State University Fowler College of Business;Member of the board of managers of FFF Enterprises, Inc. and Nufactor, Inc. since January 2021;Former board member and current member of the finance committee of Saint Vincent De Paul Village Inc. (dba Father Joes Villages);Former member of the board of Global Healthcare Exchange, LLC and Innovatix, LLC;Member of the American Institute of Certified Public Accountants and the California Society of Certified Public Accountants;Obtained a bachelor's degree in business administration and a Master of Science in accountancy from San Diego State University.
Michael J. Alkire

Michael J. Alkire,2013年以来,他一直担任Premier公司的首席营运官。他曾一直担任PHSI公司和Premier公司的类似职务(2011年以来),也曾担任PHSI公司的董事会成员和Premier Plans公司的管理委员会成员(从2011年到2013年)。他于2004年加入Premier公司,担任高级副总裁,直到他被任命为Premier公司的总裁(从2006年到2011年)。他此前也曾担任德勤会计师事务所(Deloitte & Touche)和Cap Gemini Ernst & Young的执行职务。他是the East Coast Healthcare Executive Summit的成员,以及Global Healthcare Exchange公司、HSCA公司和the Dallas Mustangs(在德克萨斯州北部一个游泳项目)的董事会前任董事。他持有Indiana State University的学士学位,以及Indiana University的工商管理硕士学位。


Michael J. Alkire,Chief Executive Officer of Premier since May 2021 and President of Premier since April 2019;Chief Operating Officer of Premier (2013 to April 2019), and of PHSI and Premier LP since 2011;Senior Vice President of Premier from 2004 to 2006 and President of Premier LP from 2006 to 2011;Member of the board of directors of Premier's predecessors from 2011 to 2013;Prior executive experience includes positions at Deloitte & Touche LLP and Cap Gemini Ernst & Young;Past director on the boards of directors of FFF Enterprises, Inc., Global Healthcare Exchange, LLC and the Healthcare Supply Chain Association;Obtained a bachelor's degree from Indiana State University and a Master of Business Administration from Indiana University.
Michael J. Alkire,2013年以来,他一直担任Premier公司的首席营运官。他曾一直担任PHSI公司和Premier公司的类似职务(2011年以来),也曾担任PHSI公司的董事会成员和Premier Plans公司的管理委员会成员(从2011年到2013年)。他于2004年加入Premier公司,担任高级副总裁,直到他被任命为Premier公司的总裁(从2006年到2011年)。他此前也曾担任德勤会计师事务所(Deloitte & Touche)和Cap Gemini Ernst & Young的执行职务。他是the East Coast Healthcare Executive Summit的成员,以及Global Healthcare Exchange公司、HSCA公司和the Dallas Mustangs(在德克萨斯州北部一个游泳项目)的董事会前任董事。他持有Indiana State University的学士学位,以及Indiana University的工商管理硕士学位。
Michael J. Alkire,Chief Executive Officer of Premier since May 2021 and President of Premier since April 2019;Chief Operating Officer of Premier (2013 to April 2019), and of PHSI and Premier LP since 2011;Senior Vice President of Premier from 2004 to 2006 and President of Premier LP from 2006 to 2011;Member of the board of directors of Premier's predecessors from 2011 to 2013;Prior executive experience includes positions at Deloitte & Touche LLP and Cap Gemini Ernst & Young;Past director on the boards of directors of FFF Enterprises, Inc., Global Healthcare Exchange, LLC and the Healthcare Supply Chain Association;Obtained a bachelor's degree from Indiana State University and a Master of Business Administration from Indiana University.